Perceptive Advisors - PROTEOSTASIS THERAPEUTICS IN ownership

Quarter-by-quarter ownership
Perceptive Advisors ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2016$5,372,000
+77.1%
344,550
+37.8%
0.35%
+65.2%
Q2 2016$3,033,000
+25.9%
250,0000.0%0.21%
-0.5%
Q1 2016$2,410,000250,0000.21%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 3,804,027$17,803,0002.95%
HARBOURVEST PARTNERS LLC 440,627$2,062,0000.89%
NEA Management Company, LLC 3,556,778$16,646,0000.61%
Rock Springs Capital Management LP 450,000$2,106,0000.11%
Bain Capital Public Equity Management, LLC 263,498$1,233,0000.07%
ELEMENT CAPITAL MANAGEMENT LLC 65,973$309,0000.06%
Hillhouse Capital Management 865,923$4,053,0000.06%
SABBY MANAGEMENT, LLC 125,151$586,0000.04%
Marshall Wace North America L.P. 684,124$3,421,0000.02%
FNY Partners Fund LP 20,127$94,0000.02%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders